Form 4: Teladoc Health Executive Nikolaos P. Nanis Reports Stock Transactions
SEC Form 4 Filing
Chief Technology Officer Nikolaos P. Nanis of Teladoc Health, Inc. reports the acquisition and disposal of company stock and restricted stock units.
Summary
- On August 9, 2024, Nikolaos P. Nanis, Chief Technology Officer of Teladoc Health, Inc., acquired 568 shares of common stock through the conversion of restricted stock units.
- On August 12, 2024, Nanis disposed of 206 shares of common stock at a price of $7.135 per share to cover tax withholding obligations related to the vesting of restricted stock units.
- Following these transactions, Nanis directly owns 73,588 shares of Teladoc Health, Inc. common stock.
- The reported transactions were filed on August 13, 2024.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This Form 4 filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel at Teladoc Health.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership by a key executive.
Key Dates
| Date | Description |
|---|---|
| 08/09/2024 | Restricted stock units convert to shares of TDOC common stock. |
| 08/09/2024 | Nanis acquired 568 shares of common stock through conversion of restricted stock units. |
| 08/12/2024 | Nanis sold 206 shares at $7.135 to cover tax obligations. |
| 08/13/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.